EGFR is dispensable for c-Met-mediated proliferation and survival activities in mouse adult liver oval cells
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The adult progenitor oval cells are among the most popular and best studied liver stem/progenitor cell populations. These cells constitute a heterogeneous population that emerge and expand in the liver parenchyma as a result of chronic liver injury, subsequently differentiate into hepatocytes and are responsible for the progenitor-dependent liver regeneration [1, 2] . Besides their regenerative potential solid evidence support their involvement in liver cancer [3, 4] . This dual role emphasizes the urge to learn more about these cells.
Particularly important is to put forth efforts to dissect the signalling network regulating their development, fate and function. An increasing number of factors and signalling pathways, including growth factors, inflammatory cytokines, chemokines, and hormones, are being identified and/or postulated as major regulators of oval cell proliferation, differentiation and homeostasis, picturing a quite complex and unclear scenario. Among others, the well-known receptor tyrosine kinase (RTK) signaling systems, HGF/c-Met, and EGF/EGFR (also known as ErbB1), are certainly interesting targets for experimental studies. Both signalling pathways have a remarkably pleiotropic nature and share common intracellular signalling molecules and biological effects, playing fundamental roles during development and oncogenesis [5] [6] [7] [8] . The HGF actions, namely proliferation, survival, motility, and morphogenesis, are driven by ligand bindingdependent autophosphorylation of c-Met on specific tyrosine residues in the tyrosine kinase and C-terminal domains, followed by either adapter-mediated or direct recruitment and activation of multiple signal transducers, including Ras-ERK 1/2 mitogen activated protein kinases (MAPKs), phosphatidylinositol-3 kinase (PI3K)-AKT, phospholipase C-γ (PLC-γ), p38, and STAT3 [9] . EGF, on the other hand, binds to and activate the EGFR, which is part of a complex signalling system that includes up to 15 different ligands, transforming growth factor alpha activator of transcription-3, TGF-α, transforming growth factor-alpha; TGF-β, transforming growth factor-beta.
(TGF-α) included, and four transmembrane receptors, ErbB1 (Her1/EGFR), ErbB-2 (Her2/neu), ErbB-3 (Her3), and ErbB-4 (Her4) [10, 11] . Similarly to HGF pathway, ligand binding results in dimerization and autophosphorylation of the receptor in tyrosine residues of the cytoplasmic domain. Receptor activation leads to recruitment of adapter proteins, such as Grb2 and Shc, and subsequent activation of diverse downstream effectors, most of which are shared between the Met and ErbB1 pathways, mediating cell proliferation, migration, differentiation and evasion from apoptosis.
Evidence of a role for both HGF and TGF-α signalling systems in progenitor cellmediated regeneration is available in the literature. Indeed, both TGF-α and HGF, as well as their respective receptors, ErbB1 and c-Met, are transcriptionally up-regulated during the period of active proliferation and differentiation of progenitor cells in the rat liver subjected to the 2-acetylaminofluorene/partial hepatectomy (2-AAF/PH) protocol [12] [13] [14] . Furthermore, in vivo infusion with either EGF or HGF amplifies liver progenitor expansion following liver injury and decreases cell apoptosis [15] . Recently, using a novel in vitro model of oval cell lines harboring a genetically inactivated c-met tyrosine kinase, we have demonstrated that c-Met-supported signalling plays an essential role in promoting oval cell survival but is dispensable for proliferation [16] . We have also seen that EGF elicits mitogenic activity in mouse oval cells in vitro. However, the degree of functional redundancy, cooperation or dependence between these two signalling pathways in oval cells remains unknown. To this effect, it is well known that c-Met-signalling is modulated by direct communication with other receptors.
In fact, a direct cross-talk between c-Met and ErbB1 has been proposed in a variety of cell systems, modulating c-Met-driven downstream signalling and cellular responses. For instance, mitogenic activity of HGF on rat primary hepatocytes has been reported to be dependent on TGF-α synthesis and ErbB1 activation [17, 18] . In addition, cross-talk between these two RTKs appears to have significant implications in oncogenesis, where aberrant activation of one RTK may lead to overexpression and activation of the other [19] .
On this basis, we undertook the present study to evaluate the significance of the EGFR signalling pathway on oval cell proliferation and survival and to 
Material and Methods
Reagents and antibodies
Mouse recombinant HGF was purchased from R&D Systems (Minneapolis, MN). EGF was from Serono Laboratories (Madrid, Spain). Human recombinant TGF-β and AG1478 were from Calbiochem (La Jolla, CA).
Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS) and trypsin-EDTA were from Gibco-Invitrogen (Barcelona, Spain). Penicillin, streptomycin, HEPES, bovine serum albumin (fraction V, fatty-acid free), propidium iodide, DNA oligos, and all buffer reagents were from Sigma-Aldrich 
Cell Lines and Culture Conditions
Met flx/flx and Met -/-oval cell lines were generated as described previously [16] . Cells were routinely maintained in DMEM supplemented with 10%FBS in a humidified incubator at 37°C and a 5% CO 2 atmosphere. Medium was replaced every three days, and cells were harvested at 80% to 90% confluence using trypsin-EDTA and replated at 1:10 dilution for maintenance. After an overnight attachment period, medium was replaced by serum-free DMEM. Cells were maintained in serum-free medium for 4-12h prior to treatment with growth factors.
HGF was added before the TGF-β treatment for a minimum of 6 hours. AG1478
was added 30 min before addition of growth factors. H-thymidine during the last 40 hours of culture was measured in trichloroacetic acid precipitable material following a previously described protocol [20] .
Measurement of Apoptotic Index
The following day after cell seeding, the complete medium was replaced by serum-free DMEM with or without exogenous factors and/or inhibitor, AG1478
(5 µM), TGF-β (1 ng/ml), EGF (20 ng/ml), HGF (40 ng/ml). Cells undergoing apoptosis were scored under inverted fluorescence microscope (Eclipse TE300, Nikon) at high magnification (x60) following standard morphological criteria, such as chromatin condensation, nuclear pyknosis, and nuclear fragmentation. A cluster of closely packed apoptotic bodies was scored as one. Cells were stained with propidium iodide as described [21] and apoptotic indices were calculated after counting a minimum of 1000 cells per treatment in a blinded manner.
Measurement of Caspase-3-Like Enzymatic Activity
A fluorometric assay in the presence of Ac-DEVD-AMC as fluorogenic Caspase-3 substrate was used following a previously described procedure [22] .
Cleavage of the substrate was monitored in a Microplate Fluorescence Reader FL600 (Bio-Tek) (excitation, 380 nm; emission, 440 nm). A unit of caspase activity is the amount of enzyme that will lead to a one unit increase in the fluorescence intensity. Protein concentration was estimated and results are expressed as units of activity per microgram of protein.
Immunoprecipitation and Immunoblotting
For phospho-EGFR immunoprecipitation, cells were lysed in a buffer containing 50 mM Tris, pH7.5; 150 mM sodium chloride; 1% NP-40; 5 mM EGTA;
5 mM EDTA, supplemented with 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml aprotinin and leupeptin, and 1 mM sodium orthovanadate. 500-1000 µg of protein was incubated overnight at 4ºC with antibody against phospho-tyrosine. The following day, complexes were precipitated for 1h at 4ºC with anti-mouse IgG whole molecule-agarose antibody. Pellets were washed three times with the lysis buffer and heated for 5 min at 95ºC in Laemmli sample buffer for western blot analysis using an antibody against EGFR.
For Met immunoprecipitation, total cell extracts prepared with a lysis buffer containing 10 mM Tris, pH 7.4; 150 mM sodium chloride; 1% NP-40; 1% sodium deoxycholate; 0.1% SDS; 2 mM EDTA; plus protease and phosphatase inhibitors (as described above), were immunoprecipitated using a rabbit polyclonal anti-cMet antibody and protein A-agarose beads. The solubilized immunoprecipitates were processed as above and analyzed by Western blotting using an antiphosphotyrosine antibody.
For standard western blotting (without immunoprecipitation), total cell extracts were prepared in modified RIPA buffer: 30 mM Tris pH 7.5; 150 mM sodium chloride; 1% NP40; 0.5% sodium deoxycholate; 0.1% SDS; 5 mM EDTA supplemented with 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml aprotinin and leupeptin; 1 mM sodium orthovanadate. 40 to 80 µg of protein were separated in 10-12% acrylamide sodium dodecyl sulfate-polyacrylamide electrophoresis gels and blotted to Immobilon-P membranes (Millipore, Bedford, MA). Membranes were probed with the primary antibodies diluted 1:500 to 1:1000 in Tris-buffered saline containing 0.1% Tween 20 and 0.5% non-fat dried milk or 0.5% bovine serum albumin according to manufacturer's instructions. Detection was done using the enhanced chemiluminescence method and autoradiography.
Statistical Analysis
Statistical analysis was performed by Student's t-test analysis. The differences were assumed significant at P <0.05. hepatocytes [23, 24] . In vivo evidences suggest similar roles for the EGFR ligands/EGFR axis in liver progenitor cells [13, 15] . Moreover, accordingly to apoptotic index data, the AG1478-induced increase in caspase-3 activity was significantly stronger and more persistent in Met -/-cells (Fig. 2C ). These results suggest that an autocrine signalling through EGFR operates in oval cells to promote cell proliferation and survival. Our data also suggest that in the absence of c-Met-driven survival signals oval cells become more dependent on the pro-survival activity of EGFR.
Results
Oval cells express EGFR
Previously, we have reported that TGF-β induces apoptosis in oval cells
and that lack of c-Met tyrosine kinase activity makes oval cells more sensitive to the pro-apoptotic effects of this cytokine [16] . To gain greater insights into the EGFR-driven antiapoptotic activity, we also tested the effect of AG1478 on TGF- [25, 26] , our data support a critical role for EGFR in protecting against TGF-β-induced apoptosis in oval cells. Although bidirectional cross-talk between Met and EGFR might occur, a role for EGFR in Met-mediated signalling seems to be more established, particularly in hepatic cells [17, 18, 28] . Hence, we next tested the consequences of inhibiting the EGFR kinase on HGF-driven signalling. As seen in We have previously reported that HGF elicits mitogenic and anti-apoptotic activities in mouse oval cells [16] . To unequivocally assess whether or not EGFR kinase contributes to HGF-mediated activities in oval cells, we chose to analyze the effects of the inhibitor AG1478 on HGF-driven proliferation and survival. If a total or partial dependence on EGFR activity existed, an inhibition or decrease of those effects should be expected upon inhibition of EGFR. Instead, HGF-elicited increase in DNA synthesis was preserved in spite of EGFR inhibition (Fig. 6A ).
EGF-treated cells were used as positive control for the specificity and efficacy of the inhibitor. AG1478 completely prevented EGF-mediated enhancement in DNA synthesis as anticipated.
A similar approach was used for the analysis of the effect of EGFR inhibition on HGF-mediated protection against TGF-β-induced apoptosis. We have previously described that addition of exogenous HGF resulted in an approximate 50% decrease in the TGF-β-induced apoptosis [16] . The same decrease was observed when AG1478 was present (Fig. 6B) , demonstrating that the EGFR kinase is not required for the HGF pro-survival activity in oval cells.
As an additional approach to further confirm these results we silenced the Fig. 1C,D) .
These studies together demonstrate that c-Met and EGFR promote proliferation and survival of mouse oval cells independent of one another.
Discussion
The signalling pathways that control oval cell biology are only poorly understood. In this study we have directly approached the relevance of EGFR- It is well known that the EGFR and its ligands play a critical role in the proliferative response accompanying liver regeneration after partial hepatectomy [23] . In fact, mice lacking EGFR showed a delay in liver regeneration due to a reduced hepatocyte proliferation and cell cycle progression [31] . In contrast, scarce data is available in the literature regarding EGFR signalling in progenitormediated liver regeneration. The fact that infusion of TGF-α increases oval cell proliferation after 2-AAF/PH protocol [15] suggested that EGFR signalling is also an important regulator of liver progenitor cells proliferation in a regenerative context, but for now, the impact of deleting EGFR signalling in liver regeneration from oval progenitor cells remains undefined. Interestingly, TGF-α transcripts are undetectable or very low in normal liver or non-replicating hepatocytes, but are up-regulated in hepatocytes during partial hepatectomy and toxic injury [32, 33] as well as in proliferating oval cells and basophilic foci of hepatocytes in regenerating liver induced by a modified Solt-Farber protocol [12] , providing indirect evidence for the implication of an autocrine mechanism. Here, using in vitro approaches we present the first direct evidence of the autocrine action of EGFR ligands in non-tumorigenic oval cells. This is supported by constitutive expression of EGFR ligands (Fig. 1A) and activation of EGFR (Fig. 1B) ; as well as a decrease in basal proliferation rate and increased apoptosis upon inhibition of EGFR kinase (Fig. 2) . Remarkably, the EGFR inhibitor almost completely inhibits endogenous oval cell proliferation ( Fig. 2A) , resembling the response seen in hepatoma cells [34] . Similar results have also been reported in adult rat hepatocytes [18] using PKI166, a dual EGFR/ErbB2 inhibitor, although the inhibitory effect was not as strong as that observed in oval cells using AG1478.
More importantly, the presence of c-Met tyrosine kinase cannot override the potent inhibitory effect of AG1478 on cell proliferation ( Fig. 2A) . This, together with our previous results showing that lack of c-Met tyrosine kinase activity has no effect on oval cell proliferation [16] , strongly suggest a major role for EGFR in regulation of oval cell proliferation.
It is well known that EGFR-dependent signalling integrates proliferative
and survival signals in hepatocytes. Indeed, we and others have previously reported that EGF induces proliferation [20] and protects hepatocytes from various apoptotic insults, including TGF-β, Fas, and deoxycholic acid [25, 35, 36] .
Furthermore, EGFR is activated and required for TGF-β-induction of antiapoptotic signals, such as AKT [22] , constituting a part of the mechanism induced by TGF-β to confer resistance to apoptosis in fetal hepatocytes after an EMT process [37] . Consistent with these data, we see an increased apoptotic index under serum deprivation as well as TGF-β treatment in the presence of AG1478 ( Fig. 2B-D) . We have not explored in detail the mechanisms involved in the EGFR autocrine antiapoptotic signalling in oval cells. However, we see a notable decrease in TGF-α mRNA levels under AG1478 treatment (data not shown), which indicates that EGFR kinase activity is required for the induction of the expression of EGFR ligands, thus activating a pro-survival amplifying loop.
On the other hand, the lower apoptosis levels displayed by serum-deprived Met flx/flx cells in the presence of AG1478 are consistent with an active Metdependent autocrine survival signalling in Met flx/flx oval cells [16] , and serve as an additional proof for the capacity of c-Met signalling to restrain the apoptotic response in oval cells. It should be pointed out that EGFR silencing did not result in an amplification of the apoptotic response in oval cells (suppl. Fig.1D ). This result was not at all surprising since we have recently described that AG1478 has broader effects than EGFR silencing on apoptosis in hepatocellular carcinoma cells [38] . These observations make clear that AG1478 might have both EGFRdependent and independent effects, and leave the door open to future studies to explore additional targets, including other members of the ErbB receptor family.
Taken altogether, our results constitute compelling evidence for a regulation of oval cell growth and survival by autocrine growth factors, i.e., HGF and EGFR ligands. At the same time, they highlight non-redundant roles for autocrine EGFR and c-Met signalling in oval cell proliferation and survival. While EGFR seems to be more important for driving proliferation, both RTKs might cooperate to protect cells against apoptotic insults. Nonetheless, c-Met appears to have some unique effects on promoting cell survival, which would explain why EGFR is not able to compensate for c-Met loss.
It is of particular interest that EGF is able to protect against TGF-β-induced apoptosis regardless the presence or absence of a functional c-Met (Fig. 4) . [18] . However, differently from oval cells, either inhibition of EGFR activity [18] or TGF-α synthesis and activity [17] , block the mitogenic effect of HGF on hepatocytes. This, together with results indicating the capability of HGF to induce TGF-α mRNA transcription in HepG2 cells [39] , suggests that in normal and tumorigenic hepatocytes, HGF might promote hepatocyte proliferation in an EGFR-dependent manner through the production of EGFR ligands. A similar transcription-dependent crosstalk between c-Met and EGFR has been established in several cell types, including malignant and untransformed cells [30, 40] , where it is required for induction of cell proliferation or motility. We prove here that this mechanism does not work in oval cells, where EGFR is not required for HGF/c-Met-driven signalling (Fig.5A and suppl. Fig.1B ) and mitogenic and anti-apoptotic activities (Fig. 6A,B and suppl. Fig.1C,D 
